DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Resminostat is an investigational drug.
There have been 5 clinical trials for Resminostat. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Hepatocellular, and Lymphoma, T-Cell. The leading clinical trial sponsors are 4SC AG, Yakult Honsha Co., LTD, and [disabled in preview].
Recent Clinical Trials for Resminostat
|Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)||4SC AG||Phase 2|
|Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)||Yakult Honsha Co., LTD||Phase 1/Phase 2|
|4SC-201 (Resminostat) in Advanced Colorectal Carcinoma||4SC AG||Phase 1/Phase 2|